Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem ; 15(11): 3783-800, 2007 Jun 01.
Article in English | MEDLINE | ID: mdl-17399986

ABSTRACT

The integrin alpha(v)beta(3), vitronectin receptor, is expressed in a number of cell types and has been shown to mediate adhesion of osteoclasts to bone matrix, vascular smooth muscle cell migration, and angiogenesis. We recently disclosed the discovery of a tripeptide Arg-Gly-Asp (RGD) mimic, which has been shown to be a potent inhibitor of the integrin alpha(v)beta(3) and has excellent anti-angiogenic properties including its suppression of tumor growth in animal models. In other investigations involving RGD mimics, only compounds containing the S-isomers of the beta-amino acids have been shown to be potent. We were surprised to find the potencies of analogs containing enantiomerically pure S-isomers of beta-amino acids which were only marginally better than the corresponding racemic mixtures. We therefore synthesized RGD mimics containing R-isomers of beta-amino acids and found them to be relatively potent inhibitors of alpha(v)beta(3). One of the compounds was examined in tumor models in mice and has been shown to significantly reduce the rate of growth and the size of tumors.


Subject(s)
Amino Acids/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Integrin alphaVbeta3/antagonists & inhibitors , Molecular Mimicry , Oligopeptides/chemistry , Oligopeptides/pharmacology , Amino Acids/chemical synthesis , Animals , Antineoplastic Agents/pharmacokinetics , Colonic Neoplasms , Hypercalcemia/chemically induced , Isomerism , Melanoma , Mice , Mice, Inbred Strains , Oligopeptides/pharmacokinetics , Skin Neoplasms , Xenograft Model Antitumor Assays
2.
Bioorg Med Chem ; 15(10): 3390-412, 2007 May 15.
Article in English | MEDLINE | ID: mdl-17387018

ABSTRACT

The integrin alpha(v)beta(3) is expressed in a number of cell types and is thought to play a major role in several pathological conditions. Various small molecules that inhibit the integrin have been shown to suppress tumor growth and retinal angiogenesis. The tripeptide Arg-Gly-Asp (RGD), a common binding motif in several ligands that bind to alpha(v)beta(3), has been depeptidized and optimized in our efforts toward discovering a small molecule inhibitor. We recently disclosed the synthesis and biological activity of several small molecules that did not contain any peptide bond and mimic the tripeptide RGD. The phenethyl group in one of the lead compounds was successfully replaced with a cyclopropyl moiety. The new lead compound was optimized for potency, selectivity, and for its ADME properties. We describe herein the discovery, synthesis, and optimization of cyclopropyl containing analogs that are potent and selective inhibitors of alpha(v)beta(3).


Subject(s)
Acetates/chemical synthesis , Acetates/pharmacology , Integrin alphaVbeta3/antagonists & inhibitors , Naphthyridines/chemical synthesis , Naphthyridines/pharmacology , Animals , Area Under Curve , Cell Line , Chromatography, High Pressure Liquid , Crystallography, X-Ray , Drug Design , Half-Life , Humans , Indicators and Reagents , Male , Mice , Rats , Rats, Sprague-Dawley , Spectrophotometry, Ultraviolet , Structure-Activity Relationship , Transfection
3.
Biochem Biophys Res Commun ; 350(1): 74-81, 2006 Nov 10.
Article in English | MEDLINE | ID: mdl-16989774

ABSTRACT

We have identified a novel human gene by transcriptional microarray analysis, which is co-regulated in tumors and angiogenesis model systems with VEGF expression. Isolation of cDNA clones containing the full-length VCC-1 transcript from both human and mouse shows a 119 amino acid protein with a 22 amino acid cleavable signal sequence in both species. Comparison of the protein product of this gene with hidden Markov models of all known proteins shows weak but significant homology with two known chemokines, SCYA17 and SCYA16. Northern analysis of human tissues detects a 1 kb band in lung and skeletal muscle. Murine VCC-1 expression can also be detected in lung as well as thyroid, submaxillary gland, epididymis, and uterus tissues by slot blot analysis. By quantitative real time RT-PCR 71% of breast tumors showed 3- to 24-fold up-regulation of VCC-1. In situ hybridization of breast carcinomas showed strong expression of the gene in both normal and transformed mammary gland ductal epithelial cells. In vitro, human microvascular endothelial cells grown on fibronectin increase VCC-1 expression by almost 100-fold. In addition, in the mouse angioma endothelial cell line PY4.1 the gene was over-expressed by 28-fold 6 h after induction of tube formation while quiescent and proliferating cells showed no change. VCC-1 expression is also increased by VEGF and FGF treatment, about 6- and 5-fold, respectively. Finally, 100% of mice injected with NIH3T3 cells over-expressing VCC-1 develop rapidly progressing tumors within 21 days while no growth is seen in any control mice injected with NIH3T3 cells containing the vector alone. These results strongly suggest that VCC-1 plays a role in angiogenesis and possibly in the development of tumors in some tissue types.


Subject(s)
Chemokines/genetics , Chemokines/metabolism , Neoplasms/metabolism , Neoplasms/pathology , Amino Acid Sequence , Animals , Cell Proliferation , Cells, Cultured , Chemokines/chemistry , Chemokines, CXC , Conserved Sequence , Female , Humans , Mice , Molecular Sequence Data , Neoplasm Transplantation , Neoplasms/genetics , Sequence Alignment , Sequence Homology, Amino Acid
4.
Bioorg Med Chem Lett ; 16(12): 3156-61, 2006 Jun 15.
Article in English | MEDLINE | ID: mdl-16621534

ABSTRACT

We describe a series of pyrazole and isoxazole analogs as antagonists of the alpha(v)beta3 receptor. Compounds showed low to sub-nanomolar potency against alpha(v)beta3, as well as good selectivity against alpha(IIb)beta3. In HT29 cells, most analogs also demonstrated significant selectivity against alpha(v)beta6. Several compounds showed good pharmacokinetic properties in rats, in addition to anti-angiogenic activity in a mouse corneal micropocket model. Compounds were synthesized in a straightforward manner from readily available glutarate precursors.


Subject(s)
Integrin alphaVbeta3/antagonists & inhibitors , Isoxazoles/chemical synthesis , Isoxazoles/pharmacology , Pyrazoles/chemical synthesis , Pyrazoles/pharmacology , Animals , Cell Line , Humans , Integrin alphaVbeta3/metabolism , Isoxazoles/chemistry , Isoxazoles/pharmacokinetics , Mice , Molecular Structure , Pyrazoles/chemistry , Pyrazoles/pharmacokinetics , Rats , Structure-Activity Relationship
5.
Bioorg Med Chem Lett ; 14(6): 1471-6, 2004 Mar 22.
Article in English | MEDLINE | ID: mdl-15006384

ABSTRACT

We describe a series of conformationally-restricted cinnamic acid peptidomimetics as well as several cinnamic acid isosteres, including 3-phenylpropionic acids, 2-amino-3-phenylpropionic acids, phenoxyacetic acids and 2-phenylcyclopropylcarboxylic acids. Several analogues demonstrated low to sub-nanomolar potencies against alpha(v)beta(3) and greater than 200-fold selectivity against the other beta(3) integrin alpha(IIb)beta(3). In whole 293 cells, many of these analogues also showed modest selectivity against other alpha(v) integrins such as alpha(v)beta(1) and alpha(v)beta(5). These compounds were synthesized from readily available starting materials using either Heck or Mitsunobu coupling conditions.


Subject(s)
Cinnamates/chemical synthesis , Cinnamates/metabolism , Integrin alphaVbeta3/antagonists & inhibitors , Integrin alphaVbeta3/metabolism , Humans , Stereoisomerism
SELECTION OF CITATIONS
SEARCH DETAIL
...